Alzheimer’s & Parkinson’s Disease Congress (AD/PD)™ 2019: highlights from the Editor
Couldn’t attend the AD/PD™ 2019 Congress? Our Editor, Sharon Salt, provides her key highlights and takeaway messages from the event.
Browsing: Alzheimer’s disease
3D printed transparent skull grants insight into Alzheimer’s disease development
Scientists have 3D printed a transparent skull implant for mice, creating a ‘window’ to the brain for monitoring brain surface activity in real time. The implant could provide unique opportunities for research into concussions as well as Alzheimer’s and Parkinson’s diseases.
Adult hippocampal neurogenesis reduced in people with Alzheimer’s disease
Researchers have identified adult hippocampal neurogenesis (AHN) in people up to the age of 97 and have noted that ADH gradually declines in people with Alzheimer’s disease.
Aducanumab trials to be discontinued for Alzheimer’s disease
Biogen and Eisai have announced the decision to discontinue the global Phase III trials of aducanumab for Alzheimer’s disease.
Unique tau filament structures discovered in head-injury associated dementia
The Medical Research Council (MRC; London, UK) has determined the atomic structures of abnormal tau filaments related to chronic traumatic encephalopathy (CTE) and discovered that the structure is different to tau filaments seen in Alzheimer’s disease.
Could mushrooms prevent cognitive decline?
Results of a recent study indicate that regular consumption of mushrooms may decrease the risk of mild cognitive impairment.
Could an eye scan detect signs of Alzheimer’s disease?
A recently published study has suggested that a noninvasive eye scan may help detect signs of Alzheimer’s disease in a matter of seconds.
Alzheimer’s disease: hormone therapy linked to small risk increase
The long-term use of hormone-replacement therapy has been linked to a small increased risk of Alzheimer’s disease in postmenopausal women.
Cerebrospinal fluid biomarkers in neurodegenerative disorders
In this report from Future Neurology, researchers describe the application and state of development of a range of CSF biomarkers in common neurodegenerative disorders.
Blood biomarkers for neurological disease research: current status, challenge and future outlook
Much progress has been made on blood-based biomarkers for neurological diseases, though challenges in this field should be addressed before they are applied into clinical use.
